Haverford Trust Co purchased a new stake in shares of CME Group Inc. (NASDAQ:CME – Free Report) in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 62,575 shares of the financial services provider’s stock, valued at approximately $13,818,000.
Other large investors also recently modified their holdings of the company. Bridgewater Advisors Inc. purchased a new stake in shares of CME Group in the second quarter worth about $612,000. FLC Capital Advisors purchased a new stake in shares of CME Group during the 4th quarter valued at about $2,122,000. HighTower Advisors LLC lifted its position in CME Group by 6.9% during the 4th quarter. HighTower Advisors LLC now owns 352,922 shares of the financial services provider’s stock worth $96,376,000 after acquiring an additional 22,692 shares in the last quarter. TD Private Client Wealth LLC lifted its position in CME Group by 132.7% during the 4th quarter. TD Private Client Wealth LLC now owns 21,228 shares of the financial services provider’s stock worth $5,797,000 after acquiring an additional 12,105 shares in the last quarter. Finally, North Dakota State Investment Board purchased a new position in CME Group in the 4th quarter worth approximately $3,368,000. 87.75% of the stock is currently owned by hedge funds and other institutional investors.
CME Group Price Performance
Shares of CME opened at $274.98 on Friday. The firm has a market cap of $98.88 billion, a price-to-earnings ratio of 23.32, a PEG ratio of 3.20 and a beta of 0.23. The stock has a 50 day moving average of $251.17 and a 200-day moving average of $279.65. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.13. CME Group Inc. has a 52 week low of $218.31 and a 52 week high of $329.16.
CME Group Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Friday, September 25th. Shareholders of record on Wednesday, September 9th will be paid a dividend of $1.30 per share. The ex-dividend date is Wednesday, September 9th. This represents a $5.20 annualized dividend and a yield of 1.9%. CME Group’s payout ratio is presently 44.11%.
Insiders Place Their Bets
In other CME Group news, Director William R. Shepard bought 325 shares of the company’s stock in a transaction on Thursday, June 25th. The shares were bought at an average cost of $230.57 per share, with a total value of $74,935.25. Following the completion of the acquisition, the director owned 260,442 shares of the company’s stock, valued at approximately $60,050,111.94. This trade represents a 0.12% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.30% of the stock is currently owned by insiders.
Analyst Upgrades and Downgrades
CME has been the subject of several recent research reports. Wall Street Zen downgraded shares of CME Group from a “sell” rating to a “strong sell” rating in a research report on Saturday, August 1st. The Goldman Sachs Group lowered their price target on shares of CME Group from $267.00 to $245.00 and set a “sell” rating for the company in a report on Tuesday, June 30th. Barclays dropped their price target on shares of CME Group from $316.00 to $270.00 and set an “equal weight” rating on the stock in a research note on Thursday, July 9th. Rothschild & Co Redburn upgraded shares of CME Group from a “neutral” rating to a “buy” rating and boosted their price objective for the stock from $316.00 to $323.00 in a report on Thursday, June 11th. Finally, Bank of America upped their price objective on shares of CME Group from $226.00 to $230.00 and gave the company an “underperform” rating in a research report on Thursday, July 23rd. Nine equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and three have assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $288.56.
Get Our Latest Stock Analysis on CME
CME Group Company Profile
CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.
The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.
Featured Articles
- Five stocks we like better than CME Group
- 2 Biotech Stocks Shaping Up for Major Breakouts
- 3 Stocks Came Roaring Back—Now They’re Flashing Warning Signs
- 3 Beaten-Down Stocks That Haven’t Gotten the Message About the S&P 500’s Record Run
- Darden Restaurants Just Hit a 52-Week High–Is the Olive Garden Comeback Story Legit?
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.
